Table 1.
Baseline characteristics of the study participants.
| KERRYPNX | Study Group | Total (n = 464) |
p -Value | |
|---|---|---|---|---|
| Control (n = 236) |
Intervention (n = 228) |
|||
| Education level, n (%) | 0.775 | |||
| No studies | 4 (1.69%) | 3 (1.32%) | 7 (1.51%) | |
| Primary | 63 (26.69%) | 68 (29.82%) | 131 (28.23%) | |
| Secondary | 91 (38.56%) | 81 (35.53%) | 172 (37.07%) | |
| University/higher degree | 77 (32.63%) | 76 (33.33%) | 153 (32.97%) | |
| Employment status, n (%) | 0.902 | |||
| Self-employed | 28 (11.86%) | 22 (9.65%) | 50 (10.78%) | |
| Employed worker | 69 (29.24%) | 72 (31.58%) | 141 (30.39%) | |
| Unemployed | 18 (7.63%) | 14 (6.14%) | 32 (6.90%) | |
| Retired | 99 (41.95%) | 97 (42.54%) | 196 (42.24%) | |
| Others | 20 (8.47%) | 22 (9.65%) | 42 (9.05%) | |
| Hypertension, n (%) | 173 (73.31%) | 161 (70.61%) | 334 (71.98%) | 0.374 |
| Antihypertensive treatment, n (%) | 157 (66.53%) | 147 (64.47%) | 304 (65.52%) | 0.642 |
| Dyslipidemia, n (%) | 171 (72.46%) | 175 (76.75%) | 346 (74.57%) | 0.112 |
| Lipid-lowering treatment, n (%) | 139 (58.90%) | 138 (60.53%) | 277 (59.70%) | 0.721 |
| Type 2 diabetes, n (%) | 160 (67.80%) | 160 (70.18%) | 320 (68.97%) | 0.242 |
| Hypoglycemic agents, n (%) | 146 (61.86%) | 145 (63.60%) | 291 (62.72%) | 0.700 |
| Antiplatelet, n (%) | 43 (18.22%) | 29 (12.72%) | 72 (15.52%) | 0.102 |
Percentages and p-value were calculated taking into account the category of missing values (values not shown).